Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Daily Archives: March 14, 2019

Monepantel Tablets Positive Performance in Phase I

News & Announcements 2019By Richard Mollard March 14, 2019

190314_PhaseI part A

Recent Articles

31 July, Top 20 Shareholders
August 1, 2020
28 July Appendix 4C and Quarterly Update
July 28, 2020
13 July, Final Report delivered under Option Agreement
July 13, 2020
Epichem Corporate Presentation July 2020
July 2, 2020

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

Retweet on Twitter PharmAust Retweeted

Epichem @epichem·

Epichem welcomes the opportunity to broaden our service and product offerings working together with @BoronMolecular in partnership, providing successful product and service solutions to our global clients.
Read more ... https://www.boronmolecular.com/partners-with-epichem/

Reply on Twitter 1292992625184628736 Retweet on Twitter 12929926251846287363 Like on Twitter 12929926251846287369 Twitter 1292992625184628736

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions